Alert detail
LCD L39479: MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma — WPS
What changed
WPS final LCD sets melanoma molecular assay coverage rules eff. 5/1/25
Who’s affected: Dermatology billing teams · Effective: May 1, 2025
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 10 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.